Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders

 
 

ALEXION PHARMACEUTICALS, INC. (ALXN) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $153.73 Metrics
OS: 219.8 M -9 % ROE
Market cap: $33.8 B 43 % ROIC
Net cash: $2.96 B $13.48 per share
EV: $30.8 B

 
TTM Valuation
EBITDA
EBIT $2.8 B 10.9 x EV/EBIT
EPS ($4.65)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
Revenues6,069.94,991.14,131.23,551.13,084.12,604.02,234.01,551.3
            Revenue growth21.6%20.8%16.3%15.1%18.4%16.6%44.0%36.8%
Cost of goods sold553.5394.5374.3454.2258.3233.1174.0177.6
Gross profit5,516.44,596.63,756.93,096.92,825.82,370.92,060.01,373.8
            Gross margin90.9%92.1%90.9%87.2%91.6%91.0%92.2%88.6%
Selling, general and administrative1,399.91,261.11,111.81,094.4953.0862.6630.0489.7
Research and development1,002.9886.0730.4878.4757.2709.5514.0317.1
EBITA3,117.52,459.0732.71,124.21,115.6798.8907.0570.8
            EBITA margin51.4%49.3%17.7%31.7%36.2%30.7%40.6%36.8%
Amortization of intangibles257.6315.0321.1320.2322.2116.611.08.3
EBIT2,859.92,144.0411.6804.0793.4682.2896.0562.6
            EBIT margin47.1%43.0%10.0%22.6%25.7%26.2%40.1%36.3%
Pre-tax income569.02,178.8242.2547.8576.2498.1872.0526.3
Income taxes-34.4-225.5164.6104.5176.8353.7215.0273.4
            Tax rate  68.0%19.1%30.7%71.0%24.7%51.9%
Net income603.42,404.377.6443.3399.4144.4657.0252.9
            Net margin9.9%48.2%1.9%12.5%13.0%5.5%29.4%16.3%
 
Diluted EPS$2.72$10.70$0.35$1.97$1.76$0.67$3.25$1.27
Shares outstanding (diluted)222.0224.8224.5225.4226.3215.9202.0199.7
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy